A Phase I, Multicenter, Open-Label, Multi-Part, Dose-escalation Study of RAD1901 in Postmenopausal Women With Advanced Estrogen Receptor Positive and HER2-Negative Breast Cancer
PHASE1
The purpose of this study is to evaluate the safety, tolerability and preli...
Taxane Combined Targeted Therapy for Low-risk HER2 Positive and Lymph Node Negative Breast Cancer
N/A
Human epidermal growth factor receptor 2 (HER2) positive breast cancer is a...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2015-01-01
Trial ID
NCT06711055
Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial
NA
The goal of this interventional clinical trial is to compare the efficacy o...